The Worldwide Network for Blood & Marrow Transplantation (WBMT) and UT Health Science Center San Antonio launch a comprehensive CAR-T and Cellular Therapy Survey to understand global availability and accessibility of advanced cell-based therapies, with the aim of achieving equity of access to life-saving treatments worldwide and aiding the World Health Organization (WHO) in understanding the crucial scientific, clinical, and regulatory components of cell therapy across different regions.
The Worldwide Network for Blood & Marrow Transplantation (WBMT), in collaboration with UT Health Science Center San Antonio, has launched a comprehensive survey to gather data on CAR-T and cellular therapy worldwide. This survey aims to understand the availability, accessibility, manufacturing capabilities, accreditation, regulatory frameworks, and legal oversight of these innovative cell-based therapies. By collecting this information, the survey intends to foster discussions with the World Health Organization (WHO) and work towards achieving equitable access to life-saving treatments globally.
The Purpose of the Survey The primary objective of this survey is to gather critical data on CAR-T therapy, investigational cellular therapies, and other advanced cell-based treatments, such as mesenchymal stromal cells. The survey seeks to explore the landscape of these therapies across different regions and provide insights into the scientific, clinical, and regulatory components necessary to ensure equitable access. The data collected will facilitate discussions with the WHO and aid in shaping future initiatives to enhance access to these transformative treatments.
Survey Details The survey is a fact-finding exercise, and all responses will be handled with strict confidentiality. Only the primary investigators for this survey will have access to individual data and responses. The results will be presented by region/country rather than by specific institutions, ensuring privacy and anonymity. It is important to note that even institutions without any form of cell therapy are encouraged to participate, as their input will contribute to a comprehensive understanding of the global landscape.
Survey Logistics Participation in this survey is completely voluntary, but strong encouragement is given due to its potential impact on improving access to life-saving treatments. The survey can be accessed via the provided link:
To ensure easy access, the following steps are recommended:
Use a laptop or desktop computer to complete the survey.
Connect to a secure and steady WiFi network.
Open an incognito/private browser window by pressing Ctrl+Shift+N (Command+Shift+N for Apple users) and paste the survey link into the browser's address bar.
Survey Completion Time The survey is designed to be completed in less than 15 minutes, allowing participants to provide valuable input efficiently. The information gathered will play a vital role in driving further initiatives, especially in collaboration with the WHO, to improve access to CAR-T and cellular therapies worldwide.
You may also be interested in: ICCBBA One World Award
Contact Information For any inquiries, questions, or technical issues related to the survey, please reach out to the primary investigators:
Mickey Koh, MD Hildegard Greinix, MD Mahmoud Aljurf, MD Fazal Hussain, MD at firstname.lastname@example.org or email@example.com Participating in the CAR-T and Cellular Therapy Worldwide Survey is an opportunity to contribute to the advancement of life-saving cell-based treatments. By sharing information about the availability, accessibility, and regulatory landscape of these therapies, the survey aims to foster equitable access to these transformative treatments worldwide. Your valuable input can shape future initiatives and facilitate important discussions with the World Health Organization. Take the survey today and help bridge the gap for patients in need.
Link to the survey
Visit www.isbt128.org today to learn more.